Crystallographic studies of two alcohol dehydrogenase-bound analogues of thiazole-4-carboxamide adenine dinucleotide (TAD), the active anabolite of the antitumor agent tiazofurin.

Thiazole-4-carboxamide adenine dinucleotide (TAD) is the active anabolite of the antitumor drug tiazofurin. Beta-methylene TAD (beta-TAD) is a phosphodiesterase-resistant analogue of TAD, active in tiazofurin-resistant cells. Beta-methylene SAD (beta-SAD) is the active selenium derivative of beta-TAD. Both agents are analogues of the cofactor NAD and are capable of acting as general dehydrogenase inhibitors. Crystal structures of beta-TAD and beta-SAD bound to horse liver alcohol dehydrogenase (LADH) are presented at 2.9 and 2.7 A, respectively. Both complexes crystallize in the orthorhombic space group C222(1) and are isomorphous to apo-LADH. Complexes containing beta-TAD and beta-SAD were refined to crystallographic R values of 15% and 16%, respectively, for reflections between 8 A and the minimum d spacing. Conformations of both inhibitors are similar. beta-TAD and beta-SAD bind to the "open" form of LADH in the normal cofactor-binding cleft between the coenzyme and catalytic domains of each monomer. Binding at the adenosine end of each inhibitor resembles that of NAD. However, the positions of the thiazole and selenazole heterocycles are displaced away from the catalytic Zn cation by approximately 4 A. Close intramolecular S-O and Se-O contacts observed in the parent nucleoside analogues are maintained in both LADH-bound beta-TAD and beta-SAD, respectively. These conformational constraints may influence the binding specificity of the inhibitors.

[1]  H. Eklund,et al.  Three-dimensional structure of horse liver alcohol dehydrogenase at 2-4 A resolution. , 1976, Journal of molecular biology.

[2]  M. Sundaralingam,et al.  Conformational analysis of the sugar ring in nucleosides and nucleotides. A new description using the concept of pseudorotation. , 1972, Journal of the American Chemical Society.

[3]  V. Marquez,et al.  Dehydrogenase binding by tiazofurin anabolites. , 1990, Journal of medicinal chemistry.

[4]  K. Houk,et al.  Theoretical evaluation of conformational preferences of NAD+ and NADH: an approach to understanding the stereospecificity of NAD+/NADH-dependent dehydrogenases , 1991 .

[5]  G. Chapuis,et al.  Packing characteristics of the aliphatic chains in bis(n-alkylammonium) tetrachlorozincate(II) with even and odd numbers of carbon atoms , 1983 .

[6]  G. Tricot,et al.  Tiazofurin: biological effects and clinical uses. , 1990, International journal of cell cloning.

[7]  F. Temple Burling,et al.  Computational studies of nonbonded sulfur-oxygen and selenium-oxygen interactions in the thiazole and selenazole nucleosides , 1992 .

[8]  B. Goldstein,et al.  A database study of nonbonded intramolecular sulfur-nucleophile contacts. , 1993, Acta crystallographica. Section B, Structural science.

[9]  E. Cedergren-Zeppezauer.  Crystal-structure determination of reduced nicotinamide adenine dinucleotide complex with horse liver alcohol dehydrogenase maintained in its apo conformation by zinc-bound imidazole. , 1983, Biochemistry.

[10]  R. K. Robins,et al.  Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. , 1982, Biochemical pharmacology.

[11]  D. Wright.  A role for guanine ribonucleotides in the regulation of myeloid cell maturation. , 1987, Blood.

[12]  J. Sack,et al.  CHAIN — A crystallographic modeling program , 1988 .

[13]  V. Luzzati,et al.  Traitement statistique des erreurs dans la determination des structures cristallines , 1952 .

[14]  C. Branden,et al.  The crystal structure of complexes between horse liver alcohol dehydrogenase and the coenzyme analogues 3-iodopyridine-adenine dinucleotide and pyridine-adenine dinucleotide. , 1977, European journal of biochemistry.

[15]  H. Eklund,et al.  Crystal structure determinations of coenzyme analogue and substrate complexes of liver alcohol dehydrogenase: binding of 1,4,5,6-tetrahydronicotinamide adenine dinucleotide and trans-4-(N,N-dimethylamino)cinnamaldehyde to the enzyme. , 1982, Biochemistry.

[16]  H. Eklund,et al.  Binding of substrate in a ternary complex of horse liver alcohol dehydrogenase. , 1982, The Journal of biological chemistry.

[17]  H. Berman,et al.  Structural studies of a new antitumor agent: tiazofurin and its inactive analogues , 1983 .

[18]  H. Jayaram.  Biochemical mechanisms of resistance to tiazofurin. , 1985, Advances in enzyme regulation.

[19]  M Karplus,et al.  Interdomain motion in liver alcohol dehydrogenase. Structural and energetic analysis of the hinge bending mode. , 1979, The Journal of biological chemistry.

[20]  V. Marquez,et al.  Ara-tiazofurin: conservation of structural features in an unusual thiazole nucleoside. , 1988, Journal of medicinal chemistry.

[21]  Y. Sidi,et al.  Growth inhibition and induction of phenotypic alterations by tiazofurin: differential effects on MCF-7 breast cancer and HBL-100 breast cell lines. , 1989, European journal of cancer & clinical oncology.

[22]  H. Webster,et al.  Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line. , 1983, The Journal of clinical investigation.

[23]  C. R. Betts,et al.  The conversion of 2-beta-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. , 1982, Biochemical pharmacology.

[24]  D. W. Fry,et al.  Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide). , 1985, Biochemical pharmacology.

[25]  R. K. Robins,et al.  Structural studies of a new antitumor and antiviral agent: selenazofurin and its .alpha. anomer , 1985 .

[26]  G. Blackburn,et al.  Isopolar vs Isosteric Phosphonate Analogues of Nucleotides , 1985 .

[27]  R. K. Robins,et al.  Comparative in vitro studies of Tiazofurin and a selenazole analog. , 1983, Biochemical and biophysical research communications.

[28]  J. Mangum,et al.  Inosine monophosphate dehydrogenase and myeloid cell maturation. , 1987, Blood.

[29]  P. Rowley,et al.  Induction of HL60 cell differentiation by tiazofurin and its analogues: characterization and efficacy. , 1991, Blood.

[30]  Barry C. Finzel,et al.  The use of an imaging proportional counter in macromolecular crystallography , 1987 .

[31]  E. Oláh,et al.  Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Wolfgang Kabsch,et al.  Automatic indexing of rotation diffraction patterns , 1988 .

[33]  Wolfgang Kabsch,et al.  Evaluation of Single-Crystal X-ray Diffraction Data from a Position-Sensitive Detector , 1988 .

[34]  H. Eklund,et al.  Crystallographic investigations of nicotinamide adenine dinucleotide binding to horse liver alcohol dehydrogenase. , 1984, Biochemistry.

[35]  F. Collart,et al.  Expression of IMP dehydrogenase in differentiating HL-60 cells. , 1990, Blood.

[36]  S. Collins,et al.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture , 1977, Nature.

[37]  F. Collart,et al.  Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurin. , 1990, Experimental cell research.

[38]  V. Marquez,et al.  Studies on the mechanism of action of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). VI. Biochemical and pharmacological studies on the degradation of thiazole-4-carboxamide adenine dinucleotide (TAD). , 1986, Biochemical pharmacology.

[39]  H. Li,et al.  Carboxamide group conformation in the nicotinamide and thiazole-4-carboxamide rings: implications for enzyme binding. , 1992, Journal of medicinal chemistry.

[40]  Mike Carson,et al.  Ribbon models of macromolecules , 1987 .

[41]  A. Sartorelli,et al.  Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase. , 1986, Cancer research.

[42]  N. Heerema,et al.  Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity. , 1989, Cancer research.

[43]  R. Jackson,et al.  IMP dehydrogenase, an enzyme linked with proliferation and malignancy , 1975, Nature.

[44]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1977, Journal of molecular biology.

[45]  A T Brünger,et al.  Slow-cooling protocols for crystallographic refinement by simulated annealing. , 1990, Acta crystallographica. Section A, Foundations of crystallography.

[46]  L. Ehrenberg,et al.  Crystallization of Horse Liver Alcohol Dehydrogenase Complexes from Alcohol Solutions. , 1967 .

[47]  Olga Kennard,et al.  Systematic analysis of structural data as a research technique in organic chemistry , 1983 .

[48]  G. Blackburn,et al.  Monofluoro- and difluoro-methylenebisphosphonic acids: isopolar analogues of pyrophosphoric acid , 1981 .

[49]  G. N. Ramachandran,et al.  Conformation of polypeptides and proteins. , 1968, Advances in protein chemistry.

[50]  H. Eklund,et al.  Pyrazole binding in crystalline binary and ternary complexes with liver alcohol dehydrogenase. , 1982, Biochemistry.

[51]  G. Weber,et al.  Mechanism of resistance to tiazofurin in hepatoma 3924A. , 1986, Biochemical pharmacology.

[52]  C. Brändén,et al.  The conformation of adenosine diphosphoribose and 8-bromoadenosine diphosphoribose when bound to liver alcohol dehydrogenase. , 1975, European journal of biochemistry.